HPV Vaccination Initiative


Improving HPV Immunization Coverage – National Immunization Partnership with the American Pediatric Association (NIPA) Jump to: HPV Vaccination Initiative | In the News | Provider Resources | Handouts for Patients and Parents | Professional Education for Providers | Additional Resources

Initiative to Improve HPV Vaccination Rates
and Reduce HPV-Related Cancers


Human papillomavirus (HPV) vaccine is cancer prevention. However, HPV vaccine is underutilized in the United States, despite the overwhelming evidence of its safety and effectiveness. We can do better!

The Immunization Initiative is dedicated to improving Massachusetts HPV vaccination rates in an effort to reduce HPV-related cancers. This webpage contains information and resources for providers to use to increase HPV vaccination rates.

If you have any questions or would like more information, please contact Cynthia McReynolds, Program Manager, Immunization Initiative (cmcreynolds@mms.org; 781.895.9850).

Back to Top

In the News

Recently Released HPV Public Service Announcement (PSA) Videos:

National HPV Vaccination Roundtable Update, September 2017

National, Regional, State and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years – United States, 2016. MMWR. 2017;66(33);874-82.

NIS-Teen 2016 Summary with Ranking, MDPH, 8/17

CDC issues quarterly Massachusetts HPV Vaccination Report; CDC, August 2017

HPV Roundtable Monthly Update – July 2017

CDC issues quarterly Massachusetts HPV Vaccination Report; CDC, December 2016

HPV Vaccine Information Statement (VIS) – CDC, 12/2/16

ACIP Recommendations about HPV Vaccine 2-dose Schedule Published, MDPH Email, 12/22/16

Clinician FAQ: CDC Recommendations for HPV Vaccine 2-Dose Schedules , CDC, 12/16

HPV Vaccination Partner Toolkit, CDC, November 2016

CDC Recommends Only Two HPV Shots for Younger Adolescents, CDC, 10/19/16

Steps for Increasing HPV Vaccination in Practice: An Action Guide to Implement Evidence-Based Strategies for Clinicians, American Cancer Society, July 2016

Human Papillomavirus-Associated Cancers-United States, 2008-2012. MMWR. 2016;65(26);661–666.

Increasing HPV Vaccination Rates Among Adolescents: Challenges and Opportunities, Policy Lab – Center to Bridge Research, Practice and Policy, Children’s Hospital of Philadelphia (CHOP), Winter 2016

Call to Action: Addressing New and Ongoing Adolescent Vaccination Challenges, National Foundation for Infectious Diseases (NFID), 3/16

American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention, Journal of Clinical Oncology, 4/11/16

Prevalence of HPV After Introduction of the Vaccination Program in the United States. Pediatrics. 2016, 137(2): e20151968

Quality of Physician Communication about Human Papillomavirus Vaccine: Findings from a National Survey. Melissa B. Gilkey, Teri L. Malo, Parth D. Shah, Megan E. Hall, and Noel T. Brewer. Cancer Epidemiol Biomarkers Prev Published OnlineFirst October 22, 2015; doi:10.1158/1055-9965.EPI-15-0326

Practicing Gynecologist Discusses Consequences of HPV in Women in Their 30s, Rebecca Perkins, MD, M.Sc., August 2015

Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices, MMWR; March 27, 2015/64(11);300-304

Human Papillomavirus Vaccination – Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report (MMWR); August 29, 2014, Volume 63, Number 5

Long Term Study of A Quadrivalent Human Papillomavirus Vaccine. Pediatrics 2014; 134:e657-e665

Missed Opportunities for HPV Vaccination in Adolescent Girls: A Qualitative Study. Pediatrics 2014; 134:e666-e674

President’s Cancer Panel Annual Report – 2012-2013: Accelerating HPV Vaccine Uptake – Urgency for Action to Prevent Cancer, 2/14

CDC Declares HPV the 4th Largest 2014 US Health Threat, 12/13

Back to Top

Provider Resources

HPV Resource List for Providers, Fall 2017 coming soon!

HPV Vaccination Partner Toolkit – for Partners, Awardees and State Programs, CDC, 11/2016

Steps for Increasing HPV Vaccination in Practice: An Action Guide to Implement Evidence-Based Strategies for Clinicians, American Cancer Society, July 2016

Five Steps to Improve HPV Vaccination Rates, National Foundation for Infectious Diseases (NFID), 2016

Bi-National Immunization Resource Tool for Children 0 Through 18 Years, CDC, 2016

Addressing Parents’ Top Questions About HPV Vaccine, CDC, 2016

Screening Checklist for Contraindications for HPV, MenACWY, MenB and Tdap Vaccines for Teens, Immunization Action Coalition (IAC), 3/16

HPV Vaccine Information for Clinicians, CDC, November 2015

Be A Champion for HPV Vaccination, CDC-AAP Tip Sheet, August 2015

Supplemental information and guidance for vaccination providers regarding use of 9-valent HPV Vaccine, CDC, July 2015

HPV Vaccine Resources for Healthcare Professionals (provides various tools for your practice and handouts for patients and parents)

CDC Video: Doctors Recommend HPV Vaccine

CDC Matte Articles (ready-to-print and free to use in any publication)

Back to Top

Handouts for Patients and Parents

A Parent’s Guide to Preteen and Teen HPV Vaccination – Immunization Action Coalition, 1/17

HPV Vaccine: A Guide for Young Adults, Immunization Action Coalition, 1/17

HPV Vaccine for Boys and Girls – CDC, 12/16

HPV Vaccine is Safe (Gardasil) – CDC, 04/16

Three Things Parents Should Know About HPV Vaccine – Infographic, CDC, 7/15

Human Papillomavirus: What You Should Know, Children’s Hospital of Philadelphia (CHOP), Winter 2016
Spanish language version, CHOP, Winter 2016


Back to Top

Professional Education for Providers


The 4th Annual HPV/Cervical Cancer and HPV-Related Cancers Summit: Promoting Awareness and Prevention was held on Friday, November 4, 2016, at the Dana-Farber Cancer Institute, Boston, MA. Click here for more information.


The MCAAP Immunization Initiative Series includes and has included HPV-related webinars, Scroll down to see a list of upcoming webinars and webinars held to date. (Please note that continuing education credits are not available for listening to the webinar online.)

2017 HPV Webinars

Thursday, March 9, 2017, 12:00-1:00 p.m.
You Are the Key to HPV Cancer Prevention: Strategies for Raising HPV Vaccination Rates
-Communicating about HPV vaccination: Lessons learned from physicians and parents
Melissa Gilkey, PhD, Assistant Professor of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute
-Increasing HPV Vaccine Coverage through AFIX Utilization
Kathleen Shattuck, MPH or Sarah Sweet, MPH, MDPH Immunization Program

Learner Objectives
As a result of participating in this activity, learners should be able to:

  • Discuss physicians’ perceptions and communication practices related to recommending adolescent vaccines for patients, ages 11-12.
  • Review parents’ perceptions about the HPV vaccination.
  • Describe ways in which AFIX utilization can help practices to increase HPV vaccine coverage.

Click here to register for the webinar on March 9, 2017.

Thursday, January 12, 2017, 12:00-1:00 p.m.
2017 HPV Vaccination Update
-Review of ACIP Recommendation Regarding 2-Dose HPV Schedule and MA HPV Vaccination Uptake
Susan Lett, MD, MPH, Medical Director, MDPH Immunization Program
Dr. Lett’s presentation
-HPV Resource Review
Rebecca Vanucci, Immunization Outreach Coordinator, MDPH Immunization Program
Ms. Vanucci’s presentation

Webinar recording and slides (Please note that CME/CEU credit is not available for listening to the webinar recording.)

2014 – 2016 HPV Webinars – visit Immunization CME Archives

Other Professional Education Activities

Medscape HPV and Cervical Cancer CME Learning Center

Back to Top

Additional Resources

AAP Policy Statement, HPV Vaccine Recommendations; Pediatrics, Vol. 129, No. 3, March 2012; pp 602-605 (doi: 10.1542/peds.2011-3865)

CDC Vaccine Information Statements (VIS),

Human Papillomavirus Vaccine VIS – CDC (12/2/16)
HPV Vaccine – Gardasil – CDC (5/17/13)

2016 Immunization Schedules

Ask The Experts, Human Papillomavirus, IAC (CDC experts answer challenging and timely questions about HPV and HPV vaccine).

Back to Top